Preventing Pneumothorax During Transthoracic Lung Biopsy
Award amount
$147,147Program and phase
SBIR · Phase IAward year
2019Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- CAMBRIDGE POLYMER GROUP INC
- Proposal award date
- 2019-09-18
- Contract end date
- 2020-09-17
- UEI
- DKJDB8BKRGB3
- Solicitation number
- PA18-574
- Topic code
- NCI
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Preventing Pneuomothorax During Transthoracic Lung Biopsy
- Degradable hydrogel for retinal tamponade (phase 2)
- Degradable hydrogel for retinal tamponade
- An injectable biocompatible hydrogel nucleus pulposus replacement
- A Fully Integrated Commercial Multi-sample Multi-Slit Rheometer
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Mini-reflectance confocal microscope (Mini-RCM) for aiding skin cancer diagnosis and treatment
- Development of small molecule therapeutics targeting AR-V7 for prostate cancer
- Decentralized Clinical Trial of Effectiveness of EnergyPoints App to Guide Acupressure Use for Fatigue and Sleep Disturbances in Cancer Survivors
- Optimized targeted radiotherapy of pancreatic cancer
- Adaptive imaging for pioneering multiplexed spatial profiling of tumors and tissues for cancer research and diagnosis
Research funding history
13 SBIR/STTR records share this UEI (1997–2022). Reported award amounts total $3,469,773. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, National Science Foundation, Department of Commerce